Norges Bank
INDV icon

Norges Bank’s Indivior Pharmaceuticals INDV Stock Holding History

Norges Bank’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,196,814
Closed -$21.6M – 1872
2024
Q3 		$21.6M Sell
2,196,814
-143,188
-6% -$1.68M ﹤0.01% 1209
2024
Q2 		$36.7M Buy
2,340,002
+59,795
+3% +$1.08M 0.01% 1037
2024
Q1 		$48.8M Sell
2,280,207
-103,567
-4% -$1.95M 0.01% 952
2023
Q4 		$36M Hold
2,383,774
– – 0.01% 1058
2023
Q3 		$51.7M Hold
2,383,774
– – 0.01% 820
2023
Q2 		$55.2M Buy
+2,383,774
New +$54.6M 0.01% 806

Other funds holding INDV

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
SCM
Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Norges Bank's INDV Position: Q4 2024 in Review

Norges Bank sold out of Indivior Pharmaceuticals (INDV) in Q4 2024, closing a stake of 2,196,814 shares — an estimated $21.6M sold.

Norges Bank first reported a position in INDV in Q2 2023 and held it in 6 quarters. The position peaked at $55.2M in Q2 2023. 113 funds tracked by Wall St. Rank hold INDV as of Q4 2024.

  • Norges Bank reported no remaining Indivior Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Norges Bank sold 2,196,814 Indivior Pharmaceuticals shares in Q4 2024, an estimated $21.6M.
  • Norges Bank first reported a position in Indivior Pharmaceuticals in Q2 2023 and held it in 6 quarters.
  • Norges Bank's Indivior Pharmaceuticals position peaked at $55.2M in Q2 2023.
  • 113 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q4 2024.

Based on Norges Bank's 13F filing for Q4 2024, filed 12 Feb 2025.